Gracell Biotechnologies (GRCL) Earnings
|
Expand Research on GRCL
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +24.5% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +5.7% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 3/11/24 | Q423 | N/A | -$0.04 | N/A | N/A | N/A | N/A | N/A | N/A | ||
11/13/23  |
Q323 | N/A | -$0.05 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/14/23 | Q223 | -$0.06 | -$0.07 | +$0.01 | N/A | N/A | N/A |  | | Details | |
| 5/15/23 |
Q123 | -$0.07 | -$0.08 | +$0.01 | N/A | N/A | N/A | | | Details | |
| 3/13/23 | Q422 | -$0.06 | -$0.08 | +$0.02 | N/A | N/A | N/A | | | Details | |
| 11/14/22 | Q322 | -$0.07 | -$0.13 | +$0.06 | N/A | $33.33K | N/A | | | Details | |
| 8/15/22 | Q222 | -$0.29 | -$0.14 | -$0.15 | N/A | N/A | N/A | | | Details | |
| 3/9/21 |
 |
Q420 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
